ACE2 and pulmonary arterial hypertension: The objective of this review is to briefly summarize available knowledge on the role of small resistance artery disease in PAH and the contribution of the ACE2 pathway, and critically discuss their clinical relevance in the context of cardiovascular pathology associated to COVID-19.